Comparison of standard and high dosage recombinant interferon alpha 2b for treatment of children with chronic hepatitis B infection

Gurakan F., Kocak N., Ozen H., Yuce A.

PEDIATRIC INFECTIOUS DISEASE JOURNAL, vol.19, no.1, pp.52-56, 2000 (SCI-Expanded) identifier identifier identifier


Background. Interferon is currently the most useful therapeutic agent for chronic viral hepatitis. The aim of this study was to compare the efficacy of standard and high dosages of interferon in children with chronic hepatitis B virus (HBV) infection.